|Videos|February 28, 2022
CORAL Study Brings Positive News for Adults With Depression
Author(s)Sagar V. Parikh, MD, FRCPC
Coadministration of zuranolone with a standard antidepressant yields positive outcomes.
Advertisement
Sagar Parikh, MD, FRCPC, shares news about the CORAL Study examining zuranolone treatment in patients with major depressive disorder, which demonstrated a rapid and statistically significant reduction in depressive symptoms at day 3 and over the 2-week treatment period.
To read more about this study, see:
Dr Parikh is a professor of Depression and Clinical Neuroscience, and Psychiatry Sciences, at the University of Michigan.
Newsletter
Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
FDA Grants Breakthrough Therapy Designation to Alixorexton for the Treatment of Narcolepsy Type 1
2
The Winners of the Hanusol Contest for Peace: Ben Scherban, MD, and Kenneth Fung, MD
3
Zervimesine May Slow Progression of Dementia With Lewy Bodies, Phase 2 Results Show
4
Human Kindness Is a Key Advantage in Our Competition With Chatbot Therapists
5